Home

PB Ratio of Glaxosmithkline Pharmaceuticals Ltd

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PB Ratio

23.9

Last updated on: Oct 24, 2025

Key Highlights

  • The latest PB Ratio of Glaxosmithkline Pharmaceuticals Ltd is 23.9.
  • The PB ratio of the Glaxosmithkline Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Glaxosmithkline Pharmaceuticals Ltd changed from 11.6 on March 2020 to 25 on March 2025 . This represents a CAGR of 13.65% over 6 years.

Historical P/B Ratio of Glaxosmithkline Pharmaceuticals Ltd

No data available

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Cap

46,590 Cr

EPS

55.9

P/E Ratio (TTM)

49.2

P/B Ratio (TTM)

23.9

Day’s High

2760.0

Day’s Low

2681.0

DTE

0.0

ROE

47.5

52 Week High

3515.95

52 Week Low

1924.3

ROCE

64.3

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Oct 20252750.25
23 Oct 20252759.55
21 Oct 20252762
20 Oct 20252745.55
17 Oct 20252741.35
16 Oct 20252728.45
15 Oct 20252736.5
14 Oct 20252763.15
13 Oct 20252751.05
10 Oct 20252764.05

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Glaxosmithkline Pharmaceuticals Ltd Explained

46590

Market cap

115

Book Value per Share

23.9X

PB Ratio

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glaxosmithkline Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to conduct board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M

Read more

19 Apr 25

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

FAQs for PB Ratio of Glaxosmithkline Pharmaceuticals Ltd

What is the PB ratio of Glaxosmithkline Pharmaceuticals Ltd?

The current PB ratio of Glaxosmithkline Pharmaceuticals Ltd is 23.88. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Glaxosmithkline Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Glaxosmithkline Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Glaxosmithkline Pharmaceuticals Ltd calculated?

The PB ratio of Glaxosmithkline Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Glaxosmithkline Pharmaceuticals Ltd?

A high PB ratio suggests that Glaxosmithkline Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Glaxosmithkline Pharmaceuticals Ltd?

A low PB ratio of Glaxosmithkline Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Glaxosmithkline Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Glaxosmithkline Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions